Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zimmer Holdings to combine with Biomet Inc in transaction valued at $13.35 bln


Thursday, 24 Apr 2014 07:01am EDT 

Zimmer Holdings Inc and Biomet Inc's parent company:Says their respective boards have approved definitive agreement under which Zimmer will acquire Biomet in cash and stock transaction valued at about $13.35 bln, including the assumption of net debt.Transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in first quarter of 2015.Credit Suisse Securities (USA) LLC is acting as exclusive financial advisor to Zimmer and White & Case LLP is acting as legal advisor.BofA Merrill Lynch acted as lead financial and strategic advisor, and Goldman Sachs acted as co-advisor, to Biomet and shareholders on this transaction.Cleary Gottlieb Steen & Hamilton LLP is acting as Biomet's legal advisor, including as regulatory legal advisor in Europe, and Weil, Gotshal & Manges LLP is acting as regulatory legal advisor in U.S. 

Company Quote

99.45
-0.33 -0.33%
28 Aug 2014